Hrt Financial LP Emergent Bio Solutions Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.86 - $6.98 $233,164 - $874,991	125,357 New	125,357 $854,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $7.91 $795,498 - $1.98 Million	250,946 New	250,946 $853,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $645,732 - $1.15 Million	32,142 New	32,142 $674,000
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $140,061 - $222,862	-5,108 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $186,339 - $266,739	5,108 New	5,108 $209,000
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $162,594 - $219,371	-4,073 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $196,440 - $269,469	4,073 New	4,073 $205,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $463M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.